3 No-Brainer Dividend Stocks to Buy in April
Three Motley Fool contributors have dividends on their minds as the second quarter of 2024 begins. And they think they've found some no-brainer dividend stocks to buy in April. Here's why they like (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Pfizer (NYSE: PFE).
Keith Speights (AbbVie): What's better than a high-dividend yield? I'd say a high-dividend yield combined with a growing dividend. That's exactly what you'll get with AbbVie.
Let's start with the biopharmaceutical company's dividend yield of nearly 3.6%. High yields aren't unusual for AbbVie. The yield has topped 3% throughout most of its history.
Source Fool.com
AbbVie Inc. Stock
€171.90
0.400%
With 32 Buy predictions and not a single Sell prediction AbbVie Inc. is an absolute favorite of our community.
With a target price of 180 € there is a slightly positive potential of 4.71% for AbbVie Inc. compared to the current price of 171.9 €.
